Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours

Hong Kong Medical Journal

Volumn 15, Issue 6, 2009, Pages 463-470

  Tiu, S C ^a   Chan, Angel O K ^a   Taylor, Norman F ^b   Lee, C Y ^c   Loung, P Y ^d   Choi, C H ^a   Shek, C C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Adrenocortical adenoma; Adrenocortical carcinoma; Steroids urine

Indexed keywords

5 PREGNENE 3ALPHA,16ALPHA,20ALPHA RIOL; 5 PREGNENE 3BETA,16ALPHA,20ALPHA RIOL; CARBOPLATIN; CISPLATIN; ETOPOSIDE; MITOTANE; STEROID; THALIDOMIDE; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; POSITRON EMISSION TOMOGRAPHY; STEROID EXCRETION; STEROID METABOLISM; STEROID URINE LEVEL;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEROIDS; YOUNG ADULT;

EID: 76749160797     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr Opin Oncol 2003;15:84-90.
2. Abiven G, Coste J, Groussin L, et al. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 2006;91:2650-5.
3. Boyar RM, Nogeire C, Fukushima D, Hellman L, Fishman J. Studies of the diurnal pattern of plasma corticosteroids and gonadotropins in 2 cases of feminizing adrenal carcinoma: measurements of estrogen and corticosteroid production. J Clin Endocrinol 1977;44:39-45.
4. Minowada S, Kinoshita K, Hara M, Isurugi K, Uchikawa T, Niijima T. Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma. Endocrinol Jpn 1985;32:29-37.
5. Gröndal S, Eriksson B, Hagenäs L, Werner S, Curstedt T. Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol (Copenh) 1990;122:656-63.
6. Kikuchi E, Yanaihara H, Nakashima J, et al. Urinary steroid profile in adrenocortical tumors. Biomed Pharmacother 2000;54 Suppl 1:194s-197s.
7. Yoshimoto T, Naruse M, Ito Y, et al. Adrenocortical carcinoma manifesting pure primary aldosteronism: a case report and analysis of steroidogenic enzymes. J Endocrinol Invest 2000;23:112-7.
8. Norton JA, Doppinan JI, Jensen RT. Cancer of the endocrine system. In: Cancer: principles and practice of oncology. Philadelphia: JB Lippincott Co; 1989: 1269-344.
9. Chan AO, Taylor NF, Tiu SC, Shek CC. Reference intervals of urinary steroid metabolites using gas chromatography-mass spectrometry in Chinese adults. Steroids 2008;73:828-37.
10. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5-11.
11. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-9.
12. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-84.
13. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-37.
14. Schteingart DE. Current perspective in the diagnosis and treatment of adrenocortical carcinoma. Rev Endocr Metab Disord 2001;2:323-33.
15. Roman S. Adrenocortical carcinoma. Curr Opin Oncol 2006;18:36-42.
16. Tauchmanovà L, Colao A, Marzano LA, et al. Adrenocortical carcinomas: twelve-year prospective experience. World J Surg 2004;28:896-903.
17. Khorram-Manesh A, Ahlman H, Jansson S, et al. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 1998;22:605-11; discussion 611-2.
18. Honour JW, Price DA, Taylor NF, Marsden HB, Grant DB. Steroid biochemistry of virilising adrenal tumours in childhood. Eur J Pediatr 1984;142:165-9.
19. Fukushima DK, Smulowitz M, Williams KI. Δ5-Pregnene-3α, 16α,20α-triol and related steroids in adrenocortical carcinoma. J Biol Chem 1961;236:3147-50.
20. Hirschmann H, Hirschmann FB. Steroid excretion in a case of adrenocortical carcinoma. IV. delta 5 pregnanetriol-3 beta, 16 alpha, 20 alpha. J Biol Chem 1950;184:259-82.
21. Lipsett MB, Hertz R, Ross GT. Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am J Med 1963;35:374-83.